Pag-aaral pangklinika para sa COPD sa Utah
7 pag-aaral para sa COPD ang naghahanap ng mga kalahok sa mga site sa Utah.
Mga Lungsod sa Utah
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
- GSK Investigational Site, West Jordan
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780669A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-2)
- GSK Investigational Site, West Point
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT07780656WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
- Intermountain Medical Center, Murray
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT07558265A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Ogden
- Research Site, West Valley City
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06283966: Vascular Function in Health and Disease
- University of Utah, Salt Lake City
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2026 · NCT02966665A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Clearfield
Nagre-recruitPhase 3
Edad 40 hanggang 80 · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06883305SPIROMICS Study of Early COPD Progression (SOURCE)
- University of Utah, Salt Lake City
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 30 hanggang 55 · Lahat ng kasarian · Na-update Hun 3, 2026 · NCT05033990Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.